New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Aurora Cannabis Inc.
ACB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

325M

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

325M

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

5.95USD
Shape0.02 ( 0.34%)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-26%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated October 29, 2024
1W 0.68 % 1M 1.19 % 3M 1.36 % 1Y 35.84 %

Key Metrics

Shape
  • Market Cap

    325.23M


  • Shares Outstanding

    54.66M


  • Share in Float

    54.43M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    5.95


  • Average Volume

    1.13M


  • Beta

    2.713


  • Range

    2.84-9.35


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.auroramj.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.84x

P/S Ratio

0.70x

P/B Ratio

0.2

Debt/Equity

-270.0%

Net Margin

$-0.5

EPS

How ACB compares to sector?

P/E Ratio

Relative Strength

Shape

ACB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$279M

Shape314%

2024-Revenue

$0.88

Shape-137%

2024-EPS

$169M

Shape-1138%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Canaccord Genuity

upgrade

Previous: Hold

2024-02-16

Now: Positive

Canaccord Genuity

downgrade

Previous: Not converted

2022-09-21

Now: Hold

Maxim Group

downgrade

Previous: Not converted

2022-09-21

Now: Hold

Needham

initialise

Previous: Not converted

2022-09-21

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.80
vs -2.10

Q3.22

arrow
arrow

N/A

-0.80
vs -0.90

Q4.22

arrow
arrow

N/A

-1.40
vs -4.20

Q1.23

arrow
arrow

N/A

-1.50
vs -10.40

Q2.23

arrow
arrow

N/A

-0.40
vs -0.80

Q3.23

arrow
arrow

N/A

-0.50
vs -0.80

Q4.23

arrow
arrow

N/A

-0.20
vs -1.40

Q1.24

arrow
arrow

+107%

0.11
vs -1.50

Q2.24

arrow
arrow

N/A

-0.17
vs -0.40

Q3.24

arrow
arrow

N/A

-0.11
vs -0.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-8%

50.2M  vs 54.6M

Q3.22

arrow
arrow

-18%

49.3M  vs 60.1M

Q4.22

arrow
arrow

+2%

61.7M  vs 60.6M

Q1.23

arrow
arrow

+43%

72.1M  vs 50.4M

Q2.23

arrow
arrow

NA

50.2M  vs 50.2M

Q3.23

arrow
arrow

+29%

63.4M  vs 49.3M

Q4.23

arrow
arrow

+4%

64.4M  vs 61.7M

Q1.24

arrow
arrow

-7%

67.4M  vs 72.1M

Q2.24

arrow
arrow

+13%

56.7M  vs 50.2M

Q3.24

arrow
arrow

-19%

51.6M  vs 63.4M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-93%

-0.93
vs -0.93

Q3.22

arrow
arrow

-9%

-0.09
vs -0.93

Q4.22

arrow
arrow

-12%

-0.12
vs -0.09

Q1.23

arrow
arrow

+97%

0.97
vs -0.12

Q2.23

arrow
arrow

-93%

-0.93
vs 0.97

Q3.23

arrow
arrow

0%

-0.00
vs -0.93

Q4.23

arrow
arrow

-5%

-0.05
vs -0.00

Q1.24

arrow
arrow

-3%

-0.03
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

164

164
vs 186

-12%

Q4.22

arrow
arrow

233

233
vs 164

42%

Q1.23

arrow
arrow

216

216
vs 233

-7%

Q2.23

arrow
arrow

201

201
vs 216

-7%

Q3.23

arrow
arrow

209

209
vs 201

4%

Q4.23

arrow
arrow

207

207
vs 209

-1%

Q1.24

arrow
arrow

8

8
vs 207

-96%

Q2.24

arrow
arrow

3

3
vs 8

-62%

Earnings Growth

Latest News